Skip to content

Pneumothorax Kit, Motification

by Arrow Intl., Inc.

510(k) K892640

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK892640 Date11 Oct 1989ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JDL
Device Class
Class III
Regulation
21 CFR Part 888.3320
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Pneumothorax Kit, Motification is a medical device designed for the drainage and re-expansion of the lung in cases of minor pneumothorax. It includes components such as a radiopaque catheter, injection needles, and a blunt fill needle to facilitate the procedure. The kit aids in restoring lung function by removing trapped air from the pleural space.

This kit is supplied sterile and intended for single-use. It is classified under the FDA’s 510(k) pathway with a traditional clearance process, filed under the Orthopedic advisory committee. The components include an 8 French (Fr) x 6.44-inch (16 cm) radiopaque catheter over an 18-gauge (Ga) RW pneumothorax needle, along with 22 Ga and 25 Ga injection needles, and an 18 Ga blunt fill needle. The kit is regulated under FDA regulation number 888.3320 and is intended for use in clinical settings where lung re-expansion is required.

Other devices from Arrow Intl., Inc.

See all devices from Arrow Intl., Inc. →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Pneumothorax Kit, Motification, and how does it work?

    The Pneumothorax Kit, Motification is designed specifically for draining trapped air from the pleural space to restore lung function in cases of minor pneumothorax. It includes a radiopaque catheter (8 French x 16 cm), an 18-gauge RW pneumothorax needle, and additional needles (22 Ga and 25 Ga injection needles, plus an 18 Ga blunt fill needle) to facilitate the procedure. By removing air, the kit helps re-expand the lung, improving respiratory function.

  • Is this kit intended for single-use or repeated use, and how should it be stored?

    The Pneumothorax Kit, Motification is supplied sterile and explicitly intended for single-use only. Since it is sterile, it should be stored in a clean, dry environment, protected from contamination, and kept within the manufacturer’s recommended shelf-life to ensure sterility and functionality.

  • What sizes and components are included in the kit, and why is the catheter radiopaque?

    The kit includes an 8 French x 16 cm radiopaque catheter (paired with an 18-gauge RW needle), along with 22-gauge and 25-gauge injection needles and an 18-gauge blunt fill needle. The catheter is radiopaque to ensure visibility under fluoroscopy or X-ray during placement, reducing the risk of misplacement and improving procedural accuracy.

  • How was this device’s regulatory pathway determined, and what does that mean for clinicians?

    The kit was cleared through the FDA’s 510(k) pathway with a traditional clearance process, filed under the Orthopedic advisory committee (OR). This means it was deemed substantially equivalent to a legally marketed device, ensuring it meets FDA safety and effectiveness standards. Clinicians can rely on its regulatory review as part of their decision-making for treating minor pneumothorax.